A Sialylated-Bortezomib Prodrug Strategy Based on a Highly Expressed Selectin Target for the Treatment of Leukemia or Solid Tumors

被引：0
|
作者：
Mingqi Liu
Xueying Tang
Junqiang Ding
Mengyang Liu
Bowen Zhao
Yihui Deng
Yanzhi Song
机构：
[1] Shenyang Pharmaceutical University,College of Pharmacy
来源：
Pharmaceutical Research | 2019年 / 36卷
关键词：
Bortezomib; leukemia; selectin-targeting; sialic acid; tumor-targeted;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 7 条
  • [1] A Sialylated-Bortezomib Prodrug Strategy Based on a Highly Expressed Selectin Target for the Treatment of Leukemia or Solid Tumors
    Liu, Mingqi
    Tang, Xueying
    Ding, Junqiang
    Liu, Mengyang
    Zhao, Bowen
    Deng, Yihui
    Song, Yanzhi
    PHARMACEUTICAL RESEARCH, 2019, 36 (12)
  • [2] Isoelectric Point Based Dual Sensitive Peptide-Drug Conjugate Prodrug to Target Solid Tumors
    S. B. Santhosh
    M. J. N. Chandrasekar
    International Journal of Peptide Research and Therapeutics, 2020, 26 : 2225 - 2229
  • [3] Isoelectric Point Based Dual Sensitive Peptide-Drug Conjugate Prodrug to Target Solid Tumors
    Santhosh, S. B.
    Chandrasekar, M. J. N.
    INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS, 2020, 26 (04) : 2225 - 2229
  • [4] Highly Integrated Nanoplatform Based on an E-Selectin-Targeting Strategy for Metastatic Breast Cancer Treatment
    Xu, Xiao-Ling
    Zhu, Meng-Lu
    Liu, Di
    Shu, Gao-Feng
    Qi, Jing
    Lu, Yan
    Wang, Fei
    Ying, Xiao-Ying
    Chen, Jian
    Du, Yong-Zhong
    MOLECULAR PHARMACEUTICS, 2019, 16 (08) : 3694 - 3702
  • [5] Discovery of novel cMET-targeting antibody Fab drug conjugates as potential treatment for solid tumors with highly expressed cMET
    Lim, Reyna K., V
    Buschman, Matthew
    Khasanov, Alisher
    Ledesma, Arthur
    Chen, John
    Nguyen, Thanhtruc
    Guo, Joanna
    Li, Lingna
    Huang, Jonathan
    Niu, Jin
    Kerwin, Lisa
    Wang, Rengang
    Guo, Yurong
    Zhu, Tong
    Kaufmann, Gunnar
    Zhang, Yanliang
    Zhou, Heyou
    Ji, Henry
    Fu, Yanwen
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2023, 23 (11) : 1137 - 1149
  • [6] Peptide-based CAR-NK cells: A novel strategy for the treatment of solid tumors
    Wang, Qianqian
    Yuan, Xin
    Liu, Cuijuan
    Huang, Ying
    Li, Lin
    Zhu, Yimin
    BIOCHEMICAL PHARMACOLOGY, 2025, 232
  • [7] Integrin αVα6 is expressed on multiple solid tumors and is a potential therapeutic target for auristatin-based antibody-drug conjugates
    Ryan, Maureen C.
    Kostner, Heather
    Meyer, E. Bradley
    Sussman, Django
    Torrey, Lindsay
    Anderson, Martha
    Lyon, Robert
    Meyer, Dave
    Jonas, Mechthild
    van Epps, Heather
    Benjamin, Dennis
    CANCER RESEARCH, 2012, 72
1